Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Smart goals in finance clarify priorities, provide metrics, and create accountability, making it easier to track progress and adjust as needed.
22,836 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Online rumors can spread faster than facts and hit your wallet hard. This guide shows how smears become mainstream, t...
Two private school boys probation decision follows a case in which AI was used to forge 350 nude images of classmates...
Quant funds are piloting a data-pruning approach named test delete to improve backtest robustness as markets remain v...
A clear read of SERA’s Q1 2026 numbers and management commentary can shift an investor’s view of 2026. This guide bre...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...
Arm Holdings stunned markets with a powerful run, then pulled back after earnings. This guide breaks down whether thi...
A bold take from Amazon's CEO on the AI era could shift how investors price the stock. This guide breaks down what an...
WeRide (WRD) is navigating growth with ride-hailing, delivery, and autonomous tech. This Q1 2026 earnings-focused ana...
A startup unveils a proprietary lithium extraction process that dramatically shortens timelines and boosts recovery, ...
Ranger Investment Management recently boosted its WaterBridge stake, signaling potential confidence in WaterBridge In...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...